POMPANO BEACH, Fla., Dec. 13, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of Mr. Thomas J. Dugan to the position of Chairman of the Board.
Mr. Dugan brings a wealth of experience to BioStem, with proven, hands-on expertise as a senior executive who has transformed businesses, established new market opportunities, and driven growth in the face of strong competition. He has extensive experience in the wound care and surgical fields.
BioStem Technologies CEO, Jason Matuszewski, said, "I am delighted to welcome Mr. Dugan to BioStem's Board of Directors. We look forward to benefiting from his extensive leadership and industry experience as we work to optimize value for our shareholders."
Mr. Dugan co-founded 360 Life Sciences Advisors, a consultancy to private equity and venture capital firms, to assess new investment opportunities and improve performance at portfolio companies. Most recently, Mr. Dugan was the President of Integrum, Inc., the pioneer in osseointegrated orthopedic implants that improve the lives of those with limb loss. Previously, he served as Chief Executive Officer and board member at Amniox Medical, a pioneer in amniotic membrane products for wound care and surgical applications. Mr. Dugan was President at Surgiquest, Inc., President of the Americas for Smith and Nephew Wound Management, and served in senior roles at SonoSite, Datascope, and Tyco Healthcare.
Mr. Dugan served on the board of directors of Rita Medical Systems (NASDAQ:RITA), ...